Depression und Angststörung bei Psoriasispatienten

Bangemann, K.; Schulz, Wolfgang; Wohlleben, J.; Weyergraf, A.; Snitjer, I.; Werfel, Thomas; Schmid-Ott, ­Gerhard; Böhm, Dana

doi:10.1007/s00105-014-3513-9

Cited by 26 publications

(14 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…as mental ability, cognition, knowledge of disease, family conditions and family, social and environmental culture as well as available facilities (28). The study of Bangemann et al (28) (2014) in this regard concluded that according to different beliefs about psoriasis, patient's strategies for compliance with this phenomenon are different.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Meaning of Coping With Psoriasis: A Phenomenological Study

Ghorbanibirgani

Fallahi-Khoshknab

Zarea

et al. 2016

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Background: Psoriasis is a chronic mental and physical disease that leads to many challenges for people along their lives so that its compatibility and acceptance by the patient is hardly possible. Objectives: The objective of the present study was to describe and explain the experienced coping strategies by patients with Psoriasis. Methods:The present study was a qualitative phenomenological interpretation, which was conducted on people with psoriasis, who had referred to Imam Khomeini hospital of Ahvaz during June and March 2014. In this study, 15 people with psoriasis were selected based on purposive sampling and they were asked to express their life experiences regarding coping strategies. Data were collected through a deep and unstructured interview, and the method of Diekelmann et al. (1989) was used for data analysis. Results: After analysis of the texts of interviews, the main theme, which was attempt to cope with disease and four sub-themes namely "disease, the reason for spiritual promotion", "intellectual insight", "supporting behavior" and "concealing disease" were extracted, which indicated the patients' experiences when coping with psoriasis. Conclusions:The results of the present study showed that people with psoriasis experienced many challenges in order to cope with this disease, and accurate identification of these challenges and real understanding of their experiences by health professionals, and reflecting positive experiences such as spiritual promotion via their disease to other patients are recommended.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The study of Bangemann et al (28) (2014) in this regard concluded that according to different beliefs about psoriasis, patient's strategies for compliance with this phenomenon are different. Experiences of the participants in this study also showed that each of them had a special interpretation of this phenomenon.…”

Section: Discussionmentioning

confidence: 99%

The Meaning of Coping With Psoriasis: A Phenomenological Study

Ghorbanibirgani

Fallahi-Khoshknab

Zarea

et al. 2016

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

show abstract

“…Various studies have reported community and family rejection as the consequences of psoriasis (16)(17)(18). In keeping with this, the perceived stigma of patients with psoriasis has been reported about 90.2% in some studies (12,19).…”

Section: Introductionmentioning

confidence: 85%

“…Also, in an investigation of 265 patients with psoriasis in Germany (2014), 32% were depressed due to the complications of the disease. Significant associations have been identified between psoriasis symptoms and the severity of depression, as well (16). In addition, the self-esteem of female patients with psoriasis was rated poor to moderate in the US in another research study (17).…”

Section: Introductionmentioning

confidence: 98%

Experiences of Young Girls with Psoriasis: A Descriptive Phenomenological Study

et al. 2020

View full text Add to dashboard Cite

Background: Psoriasis is an inflammatory skin disease with detrimental effects on patients' physical, mental, and social health. Living with this physical skin disorder can pose a threat to patients' identity and bring about unwanted changes to their role, mental image, and lifestyle. Hence, the analysis of different experiences and perceptions of people living with psoriasis can help healthcare managers and policymakers in adopting the most efficient coping strategies. Objectives: The study aimed to explain the experiences of young girls with psoriasis. Methods: This qualitative descriptive phenomenological study was conducted using in-depth, semi-structured interviews with 10 young girls with psoriasis who referred to the Dermatology Clinics of Zahedan hospitals in 2018-2019. The participants were selected using purposive sampling and the data were analyzed by Colaizzi's method. Results: The themes describing the experiences of young girls with psoriasis included the challenging emergence of disease, indefatigability in pursuit of ineffective treatment, social stigma as a community gift to the patients, and fear of uncertain future. Conclusions: The challenges of the incidence of disease at a young age and insistence on ineffective treatments were highly evident in the experiences of patients. The patients were also concerned about the social stigma associated with the disease, which could pose further challenges to their uncertain future. According to the findings, increasing public awareness of the disease and applying psychological strategies can be effective in addressing the problems of psoriasis patients. Elevating the awareness of families to accompany the patients in treatments can also be another effective measure.

show abstract

“…clothes may stick to open areas and traumatize lesions),7 which can lead to further impairment in HRQOL. Psoriasis also impacts emotional and sexual functioning, which disrupts social interactions and intimate relationships 8, 9, 10, 11, 12, 13, 14. Sensitive issues, however, such as sexual relationships, typically are not assessed by clinicians 12.…”

Section: Introductionmentioning

confidence: 99%

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study

Blauvelt

Reich

Mehlis

et al. 2017

Acad Dermatol Venereol

View full text Add to dashboard Cite

BackgroundPsoriasis can greatly impact patients’ lives by influencing clothing worn as well as by impairing sexual functioning. Secukinumab, a human monoclonal antibody selectively neutralizing interleukin‐17A, has demonstrated good efficacy and safety in the treatment of moderate‐to‐severe psoriasis and psoriatic arthritis with a rapid onset of action and sustained response.ObjectiveThis analysis using the CLEAR study, a phase 3b double‐blind study comparing the efficacy and safety of secukinumab vs. ustekinumab in adults with moderate‐to‐severe plaque psoriasis, evaluated the treatment effects on patient's daily activities and personal relationships.MethodsImpact on daily activities (interference with home/shopping/garden, and influence on clothes worn) and impact on personal relationships (problems with partner/others, and sexual difficulties) as well as their corresponding subscales were selected from the Dermatology Life Quality Index scale and evaluated for patients treated with secukinumab vs. ustekinumab from the CLEAR study. Treatment differences in mean scores and proportions of responders (score = 0, indicating no impact) were evaluated through 52 weeks. Time to response was evaluated through Week 16.ResultsSignificant differences between secukinumab and ustekinumab were observed for daily activities and personal relationships at Week 16 and sustained through Week 52 (Week 52 response rates for daily activities: 82.9% vs. 73.5%, including interference with home/shopping/garden: 88.5% vs. 78.2%, and influence on clothes worn: 85.6% vs. 74.4%; personal relationships: 86.1% vs. 73.7%, including problems with partner/others: 86.6% vs. 74.8%, and sexual difficulties: 88.5% vs. 74.3%; all P < 0.01). The median time to response was 4 weeks for secukinumab vs. 8 weeks for ustekinumab for daily activities and personal relationships (both P < 0.05).ConclusionSecukinumab treatment helps patients with moderate‐to‐severe plaque psoriasis have a more normal life faster when compared to ustekinumab, by providing greater and sustained improvement in clothing choice and sexual functioning.

show abstract

Depression und Angststörung bei Psoriasispatienten

Cited by 26 publications

References 27 publications

The Meaning of Coping With Psoriasis: A Phenomenological Study

The Meaning of Coping With Psoriasis: A Phenomenological Study

Experiences of Young Girls with Psoriasis: A Descriptive Phenomenological Study

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study

Contact Info

Product

Resources

About